This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
REMD Biotherapeutics, Inc.
Drug Names(s): AMG 477, REMD 477, REMD477
Description: AMG 477 is an antibody antagonist to the human glucagon receptor (GCGR).
Amgen and REMD
In May 2013, REMD licensed AMG477 from AMGEN for research and clinical development.
Additional information available to subscribers only: